# Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2

> **NCT06264479** · — · TERMINATED · sponsor: **Ourotech, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Kidney Cancer
- Renal Cell Cancer Metastatic

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT06264479
- **Lead sponsor:** Ourotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-06-19
- **Primary completion:** 2025-07-25
- **Final completion:** 2025-07-25
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2025-07-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06264479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06264479, "Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06264479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*